Corvus Pharmaceuticals
Develops immune-disease and cancer therapies centered on soquelitinib.
$14.16
After-hours close+0.02 (+0.11%)
At close$14.15(−3.91%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 85.53%71.92M sharesInsiders 11.75%9.88M sharesOther 2.72%2.29M shares
Shares outstanding 84.09M · Float 72.76M · 86.5% free float
Institutions13F, as of Jun 30, 2026
188 holders · 71.92M shares · 42 new positions · 113 increased · 41 reduced · 30 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Orbimed Advisors LLC | 7.17M | 8.52% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 7.14M | 8.49% | +978.4K | Aug 7, 2026 |
| State Street Corp | 4.47M | 5.32% | +908.1K | Aug 7, 2026 |
| Price T Rowe Associates Inc /MD/ | 3.79M | 4.51% | +871.8K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 3.29M | 3.92% | +58.2K | Aug 13, 2026 |
| Adams Street Partners LLC | 3.28M | 3.90% | 0 | Aug 14, 2026 |
| Vivo Capital, LLC | 2.81M | 3.34% | 0 | Aug 14, 2026 |
| Wellington Management Group LLP | 2.73M | 3.25% | +413.1K | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Orbimed Advisors LLCincl. Orbimed Capital GP V LLC | 10.30% | 8.61M | 13D | Jan 27, 2026 ↗ |
| Richard A. Miller | 7.80% | 6.09M | 13G | Feb 13, 2026 ↗ |
| Sirenia Capital Management LP | 7.50% | 6.83M | 13G | May 15, 2026 ↗ |
| BlackRock, Inc. | 6.40% | 5.39M | 13G | Apr 27, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Peter A. Thompson | director, 10 percent owner: | 7.20M | 8.56% | Jan 30, 2026 |
| Richard A. Md Miller | director, officer: President and CEO | 2.33M | 2.77% | May 20, 2026 |
| William Benton Jones | officer: See Remarks | 173.1K | 0.21% | Jun 6, 2025 |
| Richard van den Broek | director | 160.0K | 0.19% | Apr 9, 2025 |
| David Scott Moore | director | 21.7K | 0.03% | Jun 15, 2026 |
3 ten-percent owners hold 1.54M shares by Form 4, outside the officers-and-directors figure above · 6 people have not refiled in the last 18 months (7.30M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 11, 2026 | David Scott Mooredirector | Purchase | 21,700 | $11.53 | 21,700 |
| May 18, 2026 | Richard A. Md Millerdirector, officer: President and CEO | Purchase · 2 lots | 6,932 | $12.04 | 1,195,035 |
CongressHouse and Senate disclosures
Not reported.